isoproterenol has been researched along with puerarin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Feng, YP; Zeng, GY; Zhang, LY | 1 |
Chai, XS; Wang, LY; Zhao, AP | 1 |
Chen, R; Xie, M; Xue, J | 1 |
Chen, M; Huang, Z; Li, Y; Liu, B; Liu, P; Luo, C; Ou, C; Wu, Z; Zhang, J | 1 |
Hu, XB; Li, WQ; Liu, XY; Luo, SL; Sun, TL; Tang, TT; Wu, JY; Xiang, DX | 1 |
Cheng, M; Fang, Y; Feng, J; Jin, Y; Liu, J; Liu, W; Sun, Y; Tu, L | 1 |
Du, G; Gao, Z; Li, M; Lv, Y; Qin, X; Shi, Y; Song, J; Zhou, Y | 1 |
He, K; Li, Y; Ma, L; Wang, X; Wu, L; Yang, Y | 1 |
8 other study(ies) available for isoproterenol and puerarin
Article | Year |
---|---|
[Effect of puerarin and analogues of daidzein on adrenoceptors].
Topics: Adenylyl Cyclases; Animals; Dihydroalprenolol; Dose-Response Relationship, Drug; Flavonoids; In Vitro Techniques; Isoflavones; Isoproterenol; Myocardial Contraction; Rabbits; Rats; Receptors, Adrenergic | 1984 |
[Effects of puerarin on cat vascular smooth muscle in vitro].
Topics: Animals; Cats; Dose-Response Relationship, Drug; Female; Femoral Vein; Isoflavones; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Propranolol; Renal Artery; Vasodilator Agents | 1994 |
Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression.
Topics: Animals; Biological Products; Cardiomyopathies; Cardiotonic Agents; Collagen; Disease Models, Animal; Down-Regulation; Fibrosis; Heart; Hydroxyproline; Isoflavones; Isoproterenol; Male; Mice; Mice, Inbred Strains; Myocardium; NF-kappa B; Peroxisome Proliferator-Activated Receptors; Random Allocation; RNA, Messenger; Transforming Growth Factor beta1; Up-Regulation | 2012 |
Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy.
Topics: Adenine; AMP-Activated Protein Kinases; Animals; Autophagy; Cardiomegaly; Carrier Proteins; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Isoflavones; Isoproterenol; Male; Microtubule-Associated Proteins; Myocardium; Myocytes, Cardiac; Phosphoproteins; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2015 |
Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cations; Cell Line; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Humans; Isoflavones; Isoproterenol; Mice, Inbred BALB C; Micelles; Mitochondria; Myocytes, Cardiac; Nanoparticles; Particle Size; Phosphatidylethanolamines; Phosphines; Polyethylene Glycols; Rats; Static Electricity; Tissue Distribution | 2019 |
Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: In vitro and in vivo evaluation.
Topics: Animals; Biological Availability; Caco-2 Cells; Cardiovascular Agents; Diffusion; Disease Models, Animal; Humans; Hydrogen Bonding; Isoflavones; Isoproterenol; Male; Myocardial Ischemia; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility | 2020 |
The cardioprotective effects of the new crystal form of puerarin in isoproterenol-induced myocardial ischemia rats based on metabolomics.
Topics: Animals; Cardiotonic Agents; Crystallization; Disease Models, Animal; Heart; Humans; Isoflavones; Isoproterenol; Magnetic Resonance Spectroscopy; Male; Metabolomics; Myocardial Ischemia; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2020 |
Puerarin attenuates isoproterenol‑induced myocardial hypertrophy via inhibition of the Wnt/β‑catenin signaling pathway.
Topics: Cardiomegaly; Humans; Isoflavones; Isoproterenol; RNA, Messenger; Wnt Signaling Pathway | 2022 |